Further, clinical research and patient survival analyses reveal that high GPC1 levels are associated with poor prognosis in a number of cancers including glioblastoma [7,8], pancreatic adenocarcinoma [9], bladder urothelial carcinoma, and liver hepatocellular carcinoma [7]. Here, GPC1 is linked to cancer.